Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.21 USD | -0.97% | +2.39% | +23.62% |
May. 08 | Talis Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
Financials (USD)
Sales 2022 | 4.81M | Sales 2023 | 2.13M | Capitalization | 13.57M |
---|---|---|---|---|---|
Net income 2022 | -113M | Net income 2023 | -62M | EV / Sales 2022 | -17.6 x |
Net cash position 2022 | 96.61M | Net cash position 2023 | 57.06M | EV / Sales 2023 | -20.4 x |
P/E ratio 2022 |
-0.11
x | P/E ratio 2023 |
-0.22
x | Employees | 99 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 91.69% |
Latest transcript on Talis Biomedical Corporation
1 day | -0.97% | ||
1 week | +2.39% | ||
Current month | +6.84% | ||
1 month | +11.10% | ||
3 months | +25.74% | ||
6 months | +58.52% | ||
Current year | +23.62% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Kelley
CEO | Chief Executive Officer | 52 | 20-08-31 |
Director of Finance/CFO | 51 | 21-12-31 | |
Kim Popovits
BRD | Director/Board Member | 65 | 20-07-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 56 | 16-02-29 |
Randal Scott
BRD | Director/Board Member | 66 | 13-12-31 |
Kim Popovits
BRD | Director/Board Member | 65 | 20-07-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 9.21 | -0.97% | 4,118 |
24-05-07 | 9.3 | +1.53% | 14,220 |
24-05-06 | 9.16 | +0.11% | 10,762 |
24-05-03 | 9.15 | +0.55% | 1,381 |
24-05-02 | 9.1 | +1.17% | 1,691 |
Delayed Quote Nasdaq, May 08, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+23.62% | 16.78M | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- TLIS Stock